<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IMR</journal-id>
<journal-id journal-id-type="hwp">spimr</journal-id>
<journal-title>Journal of International Medical Research</journal-title>
<issn pub-type="ppub">0300-0605</issn>
<issn pub-type="epub">1473-2300</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0300060513489477</article-id>
<article-id pub-id-type="publisher-id">10.1177_0300060513489477</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The impact of pulmonary <italic>Acinetobacter baumannii</italic> infection on the prognosis of inpatients in a neurological intensive care unit</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Mao</surname><given-names>Yong-xiang</given-names></name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Liu</surname><given-names>Guang-wei</given-names></name>
<xref ref-type="corresp" rid="corresp1-0300060513489477"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>Liang</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>Xue-feng</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Li</surname><given-names>Feng</given-names></name>
</contrib>
</contrib-group>
<aff id="aff1-0300060513489477">Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing China</aff>
<author-notes>
<corresp id="corresp1-0300060513489477">Guang-wei Liu, Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, 1 You Yi Road, Chongqing 400016, China. Email: <email>18523438683@163.com.cn</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>41</volume>
<issue>4</issue>
<fpage>1120</fpage>
<lpage>1126</lpage>
<history>
<date date-type="received"><day>12</day><month>3</month><year>2013</year></date>
<date date-type="accepted"><day>23</day><month>3</month><year>2013</year></date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec id="sec10-0300060513489477"><title>Objective</title>
<p>To investigate the impact of pulmonary <italic>Acinetobacter baumannii</italic> infection on the prognosis of patients in a Chinese neurological intensive care unit (NICU).</p>
</sec>
<sec id="sec11-0300060513489477"><title>Methods</title>
<p>Patients with pulmonary infection and positive sputum culture findings were retrospectively enrolled. Logistic regression analysis was used to determine the factors influencing prognosis. Neurological disease improvement/nonimprovement and mortality rates were assessed.</p>
</sec>
<sec id="sec12-0300060513489477"><title>Results</title>
<p>The study included 374 NICU patients with pulmonary infection (110 [29.4%] with <italic>A. baumannii</italic>, 264 [70.6%] with other micro-organisms). <italic>A. baumannii</italic> infection (OR = 2.987) and invasive mechanical ventilation (OR = 16.898) were independent factors in disease prognosis. <italic>A. baumannii</italic> infection was associated with longer NICU stay, fewer improved patients and increased mortality rate compared with other pulmonary infections.</p>
</sec>
<sec id="sec13-0300060513489477"><title>Conclusions</title>
<p><italic>A. baumannii</italic> infection prolongs the duration of the NICU stay and negatively impacts on prognosis. Prognosis of NICU patients could be improved by controlling <italic>A. baumannii</italic> infection.</p>
</sec>
</abstract>
<kwd-group>
<kwd><italic>Acinetobacter baumannii</italic></kwd>
<kwd>disease development</kwd>
<kwd>intensive care unit</kwd>
<kwd>pulmonary infection</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-0300060513489477" sec-type="intro"><title>Introduction</title>
<p>The emergence of super-bacteria that are resistant to multiple antibiotics is an unprecedented challenge facing the medical community. Novel concepts and treatments are needed to fight bacterial disease, including strict control of antibiotic use. An understanding of the frequency of different bacterial infections in varying pathological conditions and their influence on prognosis are both required for the rational use of antibiotics. Our research investigating pulmonary infection pathogens in the neurological intensive care unit (NICU) revealed <italic>Acinetobacter baumannii</italic> to be one of the most common micro-organisms found in this setting.<sup><xref ref-type="bibr" rid="bibr1-0300060513489477">1</xref></sup> The aim of the present study, therefore, was to investigate the effect of <italic>A. baumannii</italic> infection on NICU inpatient prognosis.</p>
</sec>
<sec id="sec2-0300060513489477" sec-type="methods"><title>Patients and methods</title>
<sec id="sec3-0300060513489477"><title>Study population</title>
<p>This clinical, retrospective study recruited patients with pulmonary infection and positive sputum culture findings who were admitted to (and subsequently discharged from) the NICU of The First Affiliated Hospital of Chongqing Medical University, China, between January 2006 and December 2010. The criteria for pulmonary infections included: fever (≥38℃ for &gt;2 days); cough; sticky sputum; increased leucocyte count (&gt;10 × 10<sup>9</sup>/l); and harsh breath sounds with dry and medium rales or wheezy phlegm.<sup><xref ref-type="bibr" rid="bibr2-0300060513489477">2</xref></sup> Signs of pulmonary infection were observed on chest X-radiography or computed tomography. Routine sputum specimens were submitted for analysis; bronchoalveolar lavage fluid was collected if the patient underwent tracheal intubation or tracheotomy. Bacterial identification and antibiotic susceptibility tests were performed on all specimens, using a VITEK® 2 system (bioMérieux, Marcy-l’Etoile, France) in the Department of Microbiology, The First Affiliated Hospital of Chongqing Medical University, China, with reference to <italic>Pseudomonas aeruginosa</italic> ATCC 27853, <italic>Staphylococcus aureus</italic> ATCC 25923 and <italic>Escherichia coli</italic> ATCC 25922 standard quality control strains (National Committee for Clinical Laboratory Standards, China).</p>
<p>Criteria for NICU admission, refusal and discharge were formulated according to criteria for general ICU admission<sup><xref ref-type="bibr" rid="bibr3-0300060513489477">3</xref></sup> and neurology characteristics. The standardized criteria for refusing NICU admission included brain death, chronic brain injury without acute symptoms and mental illness. Discharge criteria comprised essentially stable vital signs, including body temperature, heart rate, respiration, blood pressure fluctuating within normal range for &gt;2 days, aetiology of acute nervous system damage controlled or removed, and no requirement for ventilator support.</p>
<p>The Ethics Committee of the First Affiliated Hospital of Chongqing Medical University, China approved the study, and all patients provided written informed consent prior to enrolment.</p>
</sec>
<sec id="sec4-0300060513489477"><title>Data collection</title>
<p>The following data were collected from medical records: sex; age; medical insurance status; hypertension (systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg); diabetes; chronic obstructive pulmonary disease (COPD); coronary heart disease; <italic>A. baumannii</italic> infection; concurrent infection; use of invasive mechanical ventilation; serum albumin; haemoglobin; lymphocyte percentage; severity of disease (Acute Physiology and Chronic Health Evaluation[APACHE] II score<sup><xref ref-type="bibr" rid="bibr4-0300060513489477">4</xref></sup>); the numbers of patient improvements (unaffected or slightly affected health-related quality-of-life [HRQoL]; assessed via SF-36 questionnaire<sup><xref ref-type="bibr" rid="bibr5-0300060513489477">5</xref></sup>), nonimprovements (severely affected HRQoL) and deaths; duration of stay in the NICU; total duration of hospital stay.</p>
</sec>
<sec id="sec5-0300060513489477"><title>Statistical analyses</title>
<p>Data were presented as mean ± SD or <italic>n</italic> (%). Between-group comparisons were made using Student’s <italic>t</italic>-test or χ<sup>2</sup>-test. Logistic regression analysis was used to determine the effect of sex, age, medical insurance status, hypertension, diabetes, COPD, coronary heart disease, <italic>A. baumannii</italic> infection, concurrent infection, use of invasive mechanical ventilation, serum albumin, haemoglobin, lymphocyte percentage and APACHE II score on prognosis. Statistical analyses were performed using SPSS® software, version 13.0 (SPSS Inc., Chicago, IL, USA) for Windows®. <italic>P</italic>-values &lt; 0.05 were defined as statistically significant.</p>
</sec>
</sec>
<sec id="sec6-0300060513489477" sec-type="results"><title>Results</title>
<p>The study included 374 NICU patients with pulmonary infection and positive sputum culture findings (239 males/135 females; mean age 66.14 ± 16.88 years; age range 15–95 years). Of these, 110 patients (29.4%) were infected with <italic>A. baumannii</italic> and 264 (70.6%) were infected with other micro-organisms. <xref ref-type="table" rid="table1-0300060513489477">Table 1</xref> shows demographic and clinical characteristics and neurological diagnoses of the patients, stratified according to the presence or absence of <italic>A. baumannii</italic> infection. There were no statistically significant between-group differences in any parameter.
<table-wrap id="table1-0300060513489477" position="float"><label>Table 1.</label><caption><p>Demographic and clinical characteristics of patients with pulmonary infection admitted to a Chinese neurological intensive care unit, stratified by infecting micro-organism.</p></caption>
<graphic alternate-form-of="table1-0300060513489477" xlink:href="10.1177_0300060513489477-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Characteristic</th>
<th><italic>Acinetobacter baumannii n</italic> = 110</th>
<th>Others <italic>n</italic> = 264</th>
</tr></thead>
<tbody align="left">
<tr>
<td>Sex, males/females</td>
<td>64/46 (58.2/41.8)</td>
<td>175/89 (66.3/33.7)</td>
</tr>
<tr>
<td>Age, years</td>
<td>64.95 ± 18.40</td>
<td>66.62 ± 16.22</td>
</tr>
<tr>
<td>Insurance status</td>
</tr>
<tr>
<td> public expense</td>
<td>52 (47.3)</td>
<td>125 (47.3)</td>
</tr>
<tr>
<td> medical insurance</td>
<td>37 (33.6)</td>
<td>103 (39.0)</td>
</tr>
<tr>
<td> private expense</td>
<td>21 (19.1)</td>
<td>36 (13.6)</td>
</tr>
<tr>
<td>Hypertension</td>
<td>42 (38.2)</td>
<td>117 (44.3)</td>
</tr>
<tr>
<td>Diabetes</td>
<td>13 (11.8)</td>
<td>34 (12.9)</td>
</tr>
<tr>
<td>COPD</td>
<td>5 (4.5)</td>
<td>13 (4.9)</td>
</tr>
<tr>
<td>Coronary heart disease</td>
<td>11 (10.0)</td>
<td>25 (9.5)</td>
</tr>
<tr>
<td>Concurrent infection</td>
<td>46 (41.8)</td>
<td>91 (34.5)</td>
</tr>
<tr>
<td>Invasive mechanical ventilation</td>
<td>49 (44.5)</td>
<td>97 (36.7)</td>
</tr>
<tr>
<td>Albumin, g/l</td>
<td>35.98 ± 7.73</td>
<td>36.82 ± 6.80</td>
</tr>
<tr>
<td>Haemoglobin, g/l</td>
<td>120.57 ± 19.64</td>
<td>123.96 ± 20.18</td>
</tr>
<tr>
<td>Lymphocytes, %</td>
<td>12.76 ± 8.22</td>
<td>13.27 ± 9.69</td>
</tr>
<tr>
<td>APACHE II score<sup><xref ref-type="bibr" rid="bibr4-0300060513489477">4</xref></sup></td>
<td>15.24 ± 6.50</td>
<td>13.81 ± 6.43</td>
</tr>
<tr>
<td>Diagnosis</td>
</tr>
<tr>
<td> Cerebral infarction</td>
<td>48 (43.6)</td>
<td>123 (46.6)</td>
</tr>
<tr>
<td> Cerebral haemorrhage</td>
<td>22 (22.0)</td>
<td>55 (20.8)</td>
</tr>
<tr>
<td> Serious encephalitis</td>
<td>11 (10.0)</td>
<td>25 (9.5)</td>
</tr>
<tr>
<td> Status epilepticus</td>
<td>6 (5.5)</td>
<td>22 (8.3)</td>
</tr>
<tr>
<td> Parkinson’s disease</td>
<td>3 (2.7)</td>
<td>7 (2.7)</td>
</tr>
<tr>
<td> Guillain–Barré syndrome</td>
<td>3 (2.7)</td>
<td>6 (2.3)</td>
</tr>
<tr>
<td> Myasthenia gravis</td>
<td>4 (3.6)</td>
<td>5 (1.9)</td>
</tr>
<tr>
<td> Multiple sclerosis</td>
<td>2 (1.8)</td>
<td>2 (0.8)</td>
</tr>
<tr>
<td> Acute myelitis</td>
<td>0 (0)</td>
<td>5 (1.9)</td>
</tr>
<tr>
<td> Motor neurone disease</td>
<td>1 (0.9)</td>
<td>3 (1.1)</td>
</tr>
<tr>
<td> Other</td>
<td>10 (9.1)</td>
<td>11 (4.2)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0300060513489477"><p>Data presented as mean ± SD or <italic>n</italic> (%).</p></fn>
<fn id="table-fn2-0300060513489477"><p>No statistically significant between-group differences (<italic>P</italic> ≥ 0.05; χ<sup>2</sup>-test for categorical variables, Student’s <italic>t</italic>-test for continuous variables).</p></fn>
<fn id="table-fn3-0300060513489477"><p>COPD, chronic obstructive pulmonary disease.</p></fn></table-wrap-foot>
</table-wrap></p>
<p>Sputum culture findings are given in <xref ref-type="table" rid="table2-0300060513489477">Table 2</xref>. The majority of pulmonary infections were caused by Gram-negative bacteria (294/374 cases, 78.6%), with 54 cases (14.4%) caused by fungi and 26 cases (7.0%) caused by Gram-positive bacteria. The three most common infecting micro-organisms were <italic>A. baumannii</italic> (110 cases, 29.4%), <italic>Klebsiella pneumoniae</italic> (77 cases, 20.6%), and <italic>P. aeruginosa</italic> (69 cases, 18.5%)
<table-wrap id="table2-0300060513489477" position="float"><label>Table 2.</label><caption><p>Micro-organisms associated with pulmonary infection in patients admitted to a Chinese neurological intensive care unit (<italic>n</italic> = 374).</p></caption>
<graphic alternate-form-of="table2-0300060513489477" xlink:href="10.1177_0300060513489477-table2.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Micro-organism</th>
<th>Cases</th>
</tr></thead>
<tbody align="left">
<tr>
<td>Gram-negative bacteria</td>
<td>294 (78.6)</td>
</tr>
<tr>
<td><italic> Acinetobacter baumannii</italic></td>
<td>110 (29.4)</td>
</tr>
<tr>
<td><italic> Klebsiella pneumoniae</italic></td>
<td>77 (20.6)</td>
</tr>
<tr>
<td><italic> Pseudomonas aeruginosa</italic></td>
<td>69 (18.5)</td>
</tr>
<tr>
<td><italic> Escherichia coli</italic></td>
<td>10 (2.7)</td>
</tr>
<tr>
<td><italic> Stenotrophomonas maltophilia</italic></td>
<td>8 (2.1)</td>
</tr>
<tr>
<td><italic> Enterobacter cloacae</italic></td>
<td>6 (1.6)</td>
</tr>
<tr>
<td><italic> A. junii</italic></td>
<td>3 (0.8)</td>
</tr>
<tr>
<td><italic> Haemophilus influenzae</italic></td>
<td>3 (0.8)</td>
</tr>
<tr>
<td><italic> Serratia marcescens</italic></td>
<td>2 (0.5)</td>
</tr>
<tr>
<td><italic> Enterobacter aerogenes</italic></td>
<td>2 (0.5)</td>
</tr>
<tr>
<td> Others</td>
<td>4 (1.1)</td>
</tr>
<tr>
<td>Gram-positive bacteria</td>
<td>26 (7.0)</td>
</tr>
<tr>
<td><italic> Staphylococcus aureus</italic></td>
<td>12 (3.2)</td>
</tr>
<tr>
<td><italic> S. epidermidis</italic></td>
<td>5 (1.3)</td>
</tr>
<tr>
<td><italic> S. haemolyticus</italic></td>
<td>4 (1.1)</td>
</tr>
<tr>
<td> Others</td>
<td>5 (1.3)</td>
</tr>
<tr>
<td>Fungi</td>
<td>54 (14.4)</td>
</tr>
<tr>
<td><italic> Candida albicans</italic></td>
<td>43 (11.5)</td>
</tr>
<tr>
<td><italic> C. tropicalis</italic></td>
<td>6 (1.6)</td>
</tr>
<tr>
<td> Others</td>
<td>5 (1.3)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0300060513489477"><p>Data presented as <italic>n</italic> (%).</p></fn></table-wrap-foot>
</table-wrap></p>
<p>Logistic regression analysis revealed that <italic>A. baumannii</italic> infection (odds ratio [OR] 2.987, 95% confidence intervals [CI] 1.540, 5.794) and invasive mechanical ventilation (OR 16.898, 95% CI 8.055, 35.449) were the only independent factors for disease prognosis (<xref ref-type="table" rid="table3-0300060513489477">Table 3</xref>).
<table-wrap id="table3-0300060513489477" position="float"><label>Table 3.</label><caption><p>Logistic regression analysis of factors affecting prognosis of patients with pulmonary infection, admitted to a Chinese neurological intensive care unit (<italic>n</italic> = 374).</p></caption>
<graphic alternate-form-of="table3-0300060513489477" xlink:href="10.1177_0300060513489477-table3.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Factor</th>
<th>OR</th>
<th>95% Confidence interval</th>
</tr></thead>
<tbody align="left">
<tr>
<td>Sex</td>
<td>0.919</td>
<td>0.480, 1.761</td>
</tr>
<tr>
<td>Age</td>
<td>1.007</td>
<td>0.988, 1.027</td>
</tr>
<tr>
<td>X<sub>31</sub></td>
<td>0.566</td>
<td>0.180, 1.774</td>
</tr>
<tr>
<td>X<sub>32</sub></td>
<td>1.546</td>
<td>0.480, 4.971</td>
</tr>
<tr>
<td>Hypertension</td>
<td>1.346</td>
<td>0.692, 2.619</td>
</tr>
<tr>
<td>Diabetes</td>
<td>0.659</td>
<td>0.225, 1.930</td>
</tr>
<tr>
<td>COPD</td>
<td>1.194</td>
<td>0.295, 4.836</td>
</tr>
<tr>
<td>Coronary heart disease</td>
<td>0.521</td>
<td>0.153, 1.774</td>
</tr>
<tr>
<td><italic>A. baumannii</italic> infection</td>
<td>2.987</td>
<td>1.540, 5.794</td>
</tr>
<tr>
<td>Concurrent infection</td>
<td>1.086</td>
<td>0.567, 2.079</td>
</tr>
<tr>
<td>Invasive mechanical  ventilation</td>
<td>16.898</td>
<td>8.055, 35.449</td>
</tr>
<tr>
<td>Albumin</td>
<td>1.020</td>
<td>0.974, 1.069</td>
</tr>
<tr>
<td>Haemoglobin</td>
<td>0.994</td>
<td>0.978, 1.011</td>
</tr>
<tr>
<td>Lymphocyte percentage</td>
<td>0.975</td>
<td>0.936, 1.016</td>
</tr>
<tr>
<td>APACHE II score</td>
<td>1.036</td>
<td>0.989, 1.086</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-0300060513489477"><p>OR, odds ratio; COPD, chronic obstructive pulmonary disease.</p></fn>
<fn id="table-fn6-0300060513489477"><p>X<sub>31</sub> and X<sub>32</sub> are the dummy variables of medical insurance status in logistic regression analysis, such that X<sub>31</sub> = 0; and X<sub>32</sub> = 0 is private expense, X<sub>31</sub> = 0 and X<sub>32</sub> = 1 is medical insurance, and X<sub>31</sub> = 1 and X<sub>32</sub> = 0 is public expense.</p></fn></table-wrap-foot>
</table-wrap></p>
<p>Patients with <italic>A. baumannii</italic> infection had a significantly longer duration of stay in the NICU than those infected with other micro-organisms (<italic>P</italic> = 0.015; <xref ref-type="table" rid="table4-0300060513489477">Table 4</xref>). There was no statistically significant between-group difference in the total duration of hospitalization, however. Disease prognosis was significantly less favourable in the <italic>A. baumannii</italic> group (<italic>P</italic> = 0.002), which had significantly fewer improvements (<italic>P</italic> = 0.003) and significantly more deaths (<italic>P</italic> &lt; 0.001) than the non<italic>-A. baumannii</italic> group (<xref ref-type="table" rid="table4-0300060513489477">Table 4</xref>).
<table-wrap id="table4-0300060513489477" position="float"><label>Table 4.</label><caption><p>Prognosis and duration of stay in the neurological intensive care unit (NICU) and hospital in Chinese patients with pulmonary infection, stratified by infecting micro-organism (<italic>n</italic> = 374).</p></caption>
<graphic alternate-form-of="table4-0300060513489477" xlink:href="10.1177_0300060513489477-table4.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Items</th>
<th><italic>Acinetobacter baumannii n</italic> = 110</th>
<th>Others <italic>n</italic> = 264</th>
<th>Statistical significance</th>
</tr></thead>
<tbody align="left">
<tr>
<td>Prognosis</td>
<td><italic>P</italic> = 0.002<sup><xref ref-type="table-fn" rid="table-fn11-0300060513489477">c</xref></sup></td>
</tr>
<tr>
<td> Improvement<sup><xref ref-type="table-fn" rid="table-fn9-0300060513489477">a</xref></sup></td>
<td>57 (51.8)</td>
<td>180 (68.2)</td>
<td><italic>P</italic> = 0.003<sup><xref ref-type="table-fn" rid="table-fn11-0300060513489477">c</xref></sup></td>
</tr>
<tr>
<td> Nonimprovement<sup><xref ref-type="table-fn" rid="table-fn10-0300060513489477">b</xref></sup></td>
<td>15 (13.6)</td>
<td>37 (14.0)</td>
<td>NS<sup><xref ref-type="table-fn" rid="table-fn11-0300060513489477">c</xref></sup></td>
</tr>
<tr>
<td> Death</td>
<td>38 (34.5)</td>
<td>47 (17.8)</td>
<td><italic>P</italic> &lt; 0.001<sup><xref ref-type="table-fn" rid="table-fn9-0300060513489477">a</xref></sup></td>
</tr>
<tr>
<td>NICU stay, days</td>
<td>27.03 ± 36.33</td>
<td>18.70 ± 26.85</td>
<td><italic>P</italic> = 0.015</td>
</tr>
<tr>
<td>Hospital stay, days</td>
<td>54.40 ± 63.86</td>
<td>51.18 ± 70.94</td>
<td>NS<sup>d</sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn8-0300060513489477"><p>Data presented as <italic>n</italic> (%) or mean ± SD.</p></fn>
<fn id="table-fn9-0300060513489477"><label>a</label><p>Unaffected or slightly affected health-related quality-of-life; assessed via SF-36 questionnaire.<sup><xref ref-type="bibr" rid="bibr5-0300060513489477">5</xref></sup></p></fn>
<fn id="table-fn10-0300060513489477"><label>b</label><p>Severely affected health-related quality-of-life; assessed via SF-36 questionnaire.<sup><xref ref-type="bibr" rid="bibr5-0300060513489477">5</xref></sup></p></fn>
<fn id="table-fn11-0300060513489477"><label>c</label><p>χ<sup>2</sup>-test, <sup>d</sup>Student’s <italic>t</italic>-test.</p></fn>
<fn id="table-fn12-0300060513489477"><p>NS, not statistically significant (<italic>P</italic> ≥ 0.05).</p></fn></table-wrap-foot>
</table-wrap></p>
</sec>
<sec id="sec7-0300060513489477" sec-type="discussion"><title>Discussion</title>
<p>Pulmonary infection is the most common type of infection in the NICU<sup><xref ref-type="bibr" rid="bibr1-0300060513489477">1</xref></sup> and can aggravate the primary disease, prolong the NICU stay, increase the medical costs and threaten the life of the patient. There is a disproportionately high number of elderly patients in a typical NICU,<sup><xref ref-type="bibr" rid="bibr6-0300060513489477">6</xref></sup> as well as patients with neurological symptoms including altered consciousness. This results in difficulty diagnosing pulmonary infection (which typically presents with cough, shortness of breath and tachycardia, low-grade fever, loss of appetite and lethargy), prolonging treatment time and negatively affecting prognosis.</p>
<p>The nonfermenting, Gram-negative, conditionally pathogenic bacillus<italic> A. baumannii</italic> is widely distributed in hospital environments, and has strong resistance to moisture, heat, ultraviolet rays and chemical disinfectants.<sup><xref ref-type="bibr" rid="bibr7-0300060513489477">7</xref></sup> The <italic>A. baumannii</italic> infection rate is increasing, and was found to be the fourth most common nosocomial infection in the US<sup><xref ref-type="bibr" rid="bibr8-0300060513489477">8</xref></sup> and China.<sup><xref ref-type="bibr" rid="bibr9-0300060513489477">9</xref></sup> A single Chinese study found that <italic>A. baumannii</italic> accounted for 16% of infections in 2010,<sup><xref ref-type="bibr" rid="bibr9-0300060513489477">9</xref></sup> while another indicated that <italic>A. baumannii</italic> was responsible for 12% of nosocomial pulmonary infections in 2011.<sup><xref ref-type="bibr" rid="bibr1-0300060513489477">1</xref></sup> In the present study, <italic>A. baumannii</italic> was the pathogen in 29.4% of pulmonary infections. Taken together, these data suggest that the incidence of <italic>A. baumannii</italic> infection is increasing. Risk factors for <italic>A. baumannii</italic> infection include long-term hospitalization, ICU stay, mechanical ventilation, invasive surgery, antibiotic exposure and severe underlying disease.<sup><xref ref-type="bibr" rid="bibr10-0300060513489477">10</xref></sup> The NICU is a primary location for receiving and treating patients with emergent and severe nervous system diseases, but the risk of infection is four- to five-fold greater in the NICU than in other wards.<sup><xref ref-type="bibr" rid="bibr11-0300060513489477">11</xref></sup> It is therefore essential that medical staff practice reasonable antibiotic use and effectively prevent and control pulmonary infections.</p>
<p>In contrast to the findings of others,<sup><xref ref-type="bibr" rid="bibr10-0300060513489477">10</xref></sup> there was no effect of <italic>A. baumannii</italic> infection on the total duration of hospitalization. This inconsistency may be related to factors including disease category, economic affordability and demands on resources that were not evaluated in the current study; these should be included in further studies. The significantly longer NICU stay associated with <italic>A. baumannii</italic> infection in the present study is most likely due to the aggravating effect of infection on the neurological condition, in accordance with the findings of others.<sup><xref ref-type="bibr" rid="bibr10-0300060513489477">10</xref></sup></p>
<p>The mortality rate inpatients with <italic>A. baumannii</italic> infection was significantly higher than that of those infected with other pathogens in the present study, in agreement with others.<sup><xref ref-type="bibr" rid="bibr12-0300060513489477">12</xref></sup> Pulmonary infection has been shown to increase mortality rates in patients with cerebrovascular disease,<sup><xref ref-type="bibr" rid="bibr13-0300060513489477">13</xref></sup> and stroke associated pneumonia leads to disease aggravation and death in the hospital.<sup><xref ref-type="bibr" rid="bibr14-0300060513489477">14</xref></sup> <italic>A. baumannii</italic> infection may affect disease prognosis in two ways. First, NICU patients are susceptible to nosocomial pulmonary infections because of their own critical disease, other underlying diseases or low resistance. Cerebrovascular diseases associated with pulmonary infection have been shown to impact short-term prognosis and increase neurological impairment, such that patients with pulmonary infection experience disease exacerbation, and prolonged NICU stays and rehabilitation.<sup><xref ref-type="bibr" rid="bibr15-0300060513489477">15</xref></sup> Secondly, the prolonged NICU stay associated with <italic>A. baumannii</italic> infection in the present study may increase the risk of reinfection, which may directly affect prognosis.</p>
<p>Multidrug-resistant <italic>A. baumannii</italic> (MDRAB), extensively drug-resistant <italic>A. baumannii</italic> (XDRAB) and pan drug-resistant <italic>A. baumannii</italic> (PDRAB) are widespread,<sup><xref ref-type="bibr" rid="bibr16-0300060513489477">16</xref></sup> limiting the treatment options and increasing mortality rates and medical costs.<sup><xref ref-type="bibr" rid="bibr17-0300060513489477">17</xref></sup> In order to minimize increased <italic>A. baumannii</italic> antibiotic resistance, it is important to follow guidelines regarding the prevention and control of nosocomial infections and monitor changes in resistance and drug sensitivity.</p>
<p>In conclusion, <italic>A. baumannii</italic> infection prolongs the duration of stay in the NICU, increases the mortality rate and prolongs the rehabilitation time. Tracking and monitoring studies are required to control the infection effectively and to reduce mortality, in order to create guidelines for policies and regulations for the health care industry.</p>
</sec>
</body>
<back>
<sec id="sec8-0300060513489477"><title>Funding</title>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</sec>
<sec id="sec9-0300060513489477"><title>Declaration of conflicting interest</title>
<p>The authors declare that there are no conflicts of interest.</p>
</sec>
<ref-list><title>References</title>
<ref id="bibr1-0300060513489477"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quan</surname><given-names>FY</given-names></name><name><surname>Liu</surname><given-names>GW</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Investigation of pulmonary infection pathogens in neurological intensive care unit</article-title>. <source>Ther Clin Risk Manag</source> <year>2011</year>; <volume>7</volume>: <fpage>21</fpage>–<lpage>25</lpage>.</citation></ref>
<ref id="bibr2-0300060513489477"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garner</surname><given-names>JS</given-names></name><name><surname>Jarvis</surname><given-names>WR</given-names></name><name><surname>Emori</surname><given-names>TG</given-names></name><etal/></person-group>. <article-title>CDC definitions for nosocomial infections 1988</article-title>. <source>Am J Infect Control</source> <year>1988</year>; <volume>16</volume>: <fpage>128</fpage>–<lpage>40</lpage>.</citation></ref>
<ref id="bibr3-0300060513489477"><label>3</label><citation citation-type="journal"><collab>Guidelines for intensive care unit admission, discharge and triage</collab>. <article-title>Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine</article-title>. <source>Crit Care Med</source> <year>1999</year>; <volume>27</volume>: <fpage>633</fpage>–<lpage>638</lpage>.</citation></ref>
<ref id="bibr4-0300060513489477"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knaus</surname><given-names>WA</given-names></name><name><surname>Draper</surname><given-names>EA</given-names></name><name><surname>Wanger</surname><given-names>DP</given-names></name><etal/></person-group>. <article-title>APACHE II: a severity of disease classification system</article-title>. <source>Crit Care Med</source> <year>1985</year>; <volume>13</volume>: <fpage>818</fpage>–<lpage>829</lpage>.</citation></ref>
<ref id="bibr5-0300060513489477"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ware</surname><given-names>JE Jr</given-names></name><name><surname>Sherbourne</surname><given-names>CD</given-names></name></person-group>. <article-title>The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection</article-title>. <source>J Med Care</source> <year>1992</year>; <volume>30</volume>: <fpage>473</fpage>–<lpage>483</lpage>.</citation></ref>
<ref id="bibr6-0300060513489477"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>FY</given-names></name></person-group>. <article-title>Risk factors for nosocomial infections in senile patients of neurological departments of internal medicine and protection countermeasures(J)</article-title>. <source>Chin J Nosocomiol</source> <year>2013</year>; <volume>3</volume>: <fpage>532</fpage>–<lpage>534</lpage>.</citation></ref>
<ref id="bibr7-0300060513489477"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fadda</surname><given-names>G</given-names></name><name><surname>Spanu</surname><given-names>T</given-names></name><name><surname>Ardito</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Antimicrobial resistance among non-fermentative Gram-negative bacilli isolated from the respiratory tracts of Italian inpatients: a 3-year surveillance study by the Italian epidemiological survey</article-title>. <source>Int J Antimicrob Agents</source> <year>2004</year>; <volume>23</volume>: <fpage>254</fpage>–<lpage>261</lpage>.</citation></ref>
<ref id="bibr8-0300060513489477"><label>8</label><citation citation-type="journal"><collab>A report from the NNIS System</collab>. <article-title>National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003</article-title>. <source>J. Am J Infect Control</source> <year>2003</year>; <volume>31</volume>: <fpage>481</fpage>–<lpage>498</lpage>.</citation></ref>
<ref id="bibr9-0300060513489477"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>MJ</given-names></name></person-group>. <article-title>Changes of antimicrobial resistance among non-fermenting Gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China</article-title>. <source>Natl Med J China</source> <year>2003</year>; <volume>5</volume>: <fpage>385</fpage>–<lpage>390</lpage>.</citation></ref>
<ref id="bibr10-0300060513489477"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Munoz-Price</surname><given-names>LS</given-names></name><name><surname>Robert</surname><given-names>AW</given-names></name></person-group>. <article-title><italic>Acinetobacter</italic> infection</article-title>. <source>N Engl J Med</source> <year>2008</year>; <volume>358</volume>: <fpage>1271</fpage>–<lpage>1281</lpage>.</citation></ref>
<ref id="bibr11-0300060513489477"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>AK</given-names></name><name><surname>Anupurba</surname><given-names>S</given-names></name></person-group>. <article-title>Antibiotic sensitivity pattern or the bacteria isolated from nosocomial infections in ICU</article-title>. <source>J Commun Dis</source> <year>2002</year>; <volume>34</volume>: <fpage>257</fpage>–<lpage>263</lpage>.</citation></ref>
<ref id="bibr12-0300060513489477"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dijkshoorn</surname><given-names>L</given-names></name><name><surname>Nemec</surname><given-names>A</given-names></name><name><surname>Seifert</surname><given-names>H</given-names></name></person-group>. <article-title>An increasing threat in hospitals: multidrug-resistant <italic>Acinetobacter baumannii</italic></article-title>. <source>Nat Rev Microbiol</source> <year>2007</year>; <volume>5</volume>: <fpage>939</fpage>–<lpage>951</lpage>.</citation></ref>
<ref id="bibr13-0300060513489477"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katzan</surname><given-names>IL</given-names></name><name><surname>Cebul</surname><given-names>RD</given-names></name><name><surname>Husak</surname><given-names>SH</given-names></name><etal/></person-group>. <article-title>The effect of pneumonia on mortality among patients hospitalized for acute stroke</article-title>. <source>Neurology</source> <year>2003</year>; <volume>60</volume>: <fpage>620</fpage>–<lpage>625</lpage>.</citation></ref>
<ref id="bibr14-0300060513489477"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Indredavik</surname><given-names>B</given-names></name><name><surname>Rohweder</surname><given-names>G</given-names></name><name><surname>Naalsund</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Medical complications in a comprehensive stroke unit and an early supported discharge service</article-title>. <source>Stroke</source> <year>2008</year>; <volume>39</volume>: <fpage>414</fpage>–<lpage>420</lpage>.</citation></ref>
<ref id="bibr15-0300060513489477"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>KS</given-names></name><name><surname>Kang</surname><given-names>DW</given-names></name><name><surname>Koo</surname><given-names>JS</given-names></name><etal/></person-group>. <article-title>Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke</article-title>. <source>Eur J Neurol</source> <year>2008</year>; <volume>15</volume>: <fpage>1324</fpage>–<lpage>1331</lpage>.</citation></ref>
<ref id="bibr16-0300060513489477"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peleg</surname><given-names>AY</given-names></name><name><surname>Seifert</surname><given-names>H</given-names></name><name><surname>Paterson</surname><given-names>DL</given-names></name></person-group>. <article-title><italic>Acinetobacter baumannii</italic>: emergence of a successful pathogen</article-title>. <source>Clin Microbiol Rev</source> <year>2008</year>; <volume>21</volume>: <fpage>538</fpage>–<lpage>582</lpage>.</citation></ref>
<ref id="bibr17-0300060513489477"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>XC</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>DS</given-names></name></person-group>. <article-title>Field investigation on ICU <italic>Acinetobacter baumannii</italic> infection and risk management</article-title>. <source>Practical Preventive Medicine</source> <year>2011</year>; <volume>2</volume>: <fpage>199</fpage>–<lpage>202</lpage>. <comment>[in Chinese, English abstract]</comment>.</citation></ref>
</ref-list>
</back>
</article>